S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
S&P 500   4,274.51 (+0.02%)
DOW   33,550.27 (-0.20%)
QQQ   355.04 (+0.23%)
AAPL   170.43 (-0.89%)
MSFT   312.79 (+0.21%)
META   297.74 (-0.41%)
GOOGL   130.54 (+1.53%)
AMZN   125.98 (+0.00%)
TSLA   240.50 (-1.48%)
NVDA   424.68 (+1.33%)
NIO   8.46 (+0.59%)
BABA   86.19 (+0.33%)
AMD   98.07 (+2.20%)
T   14.87 (-1.00%)
F   12.39 (-0.32%)
MU   68.21 (+0.40%)
CGC   0.89 (-3.49%)
GE   110.89 (+0.87%)
DIS   79.90 (-0.19%)
AMC   7.57 (-4.30%)
PFE   32.10 (-0.93%)
PYPL   57.34 (-2.70%)
NFLX   377.59 (-0.44%)
NASDAQ:SWAV

Shockwave Medical (SWAV) Earnings Date, Estimates & Call Transcripts

$199.64
+3.49 (+1.78%)
(As of 04:00 PM ET)
Compare
Today's Range
$195.17
▼
$200.10
50-Day Range
$194.33
▼
$275.98
52-Week Range
$172.50
▼
$320.54
Volume
410,631 shs
Average Volume
556,823 shs
Market Capitalization
$7.34 billion
P/E Ratio
31.10
Dividend Yield
N/A
Price Target
$292.29
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Nov. 6Estimated
Actual EPS
(Aug. 7)
$0.76 Missed By -$0.09
Consensus EPS
(Aug. 7)
$0.85
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

SWAV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SWAV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Shockwave Medical Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20233$0.50$0.79$0.62 
Q2 20233$0.60$1.02$0.75 
Q3 20234$0.66$1.37$0.86 
Q4 20234$0.75$1.71$1.09 
FY 202314$2.51$4.89$3.33 
Q1 20242$0.82$1.02$0.92 
Q2 20242$0.98$1.26$1.12 
Q3 20242$1.12$1.54$1.33 
Q4 20242$1.36$1.98$1.67 
FY 20248$4.28$5.80$5.04 
Q1 20251$1.16$1.16$1.16 
Q2 20251$1.38$1.38$1.38 

SWAV Earnings Date and Information

Shockwave Medical last announced its earnings data on August 7th, 2023. The reported $0.76 earnings per share for the quarter, missing analysts' consensus estimates of $0.85 by $0.09. The business earned $180.17 million during the quarter, compared to analyst estimates of $173.79 million. Its revenue for the quarter was up 49.2% compared to the same quarter last year. Shockwave Medical has generated $6.42 earnings per share over the last year ($6.42 diluted earnings per share) and currently has a price-to-earnings ratio of 30.5. Earnings for Shockwave Medical are expected to grow by 20.78% in the coming year, from $3.61 to $4.36 per share. Shockwave Medical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 6th, 2023 based off prior year's report dates.

Shockwave Medical Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/6/2023
Estimated)		------- 
8/7/2023Q2 2023$0.85$0.76($0.09)$0.76$173.79 million$180.17 million    
5/8/2023Q1 2023$0.81$1.03+$0.22$1.03$147.30 million$161.10 million    
2/16/2023Q4 2022$0.99$3.71+$2.72$3.71$143.04 million$144.00 million    
11/7/2022Q3 2022$0.68$0.92+$0.24$0.92$125.85 million$131.33 million
8/8/2022Q2 2022$0.43$0.68+$0.25$0.68$107.51 million$120.70 million      
5/9/2022Q1 2022$0.19$0.39+$0.20$0.39$86.41 million$93.70 million    
2/17/2022Q4 2021$0.07$0.34+$0.27$0.34$75.27 million$84.18 million    
11/8/2021Q3 2021($0.07)$0.05+$0.12$0.05$61.21 million$65.16 million    
8/9/2021Q2 2021($0.40)($0.01)+$0.39($0.01)$45.21 million$55.90 million    
5/10/2021Q1 2021($0.42)($0.68)($0.26)($0.68)$31.33 million$31.90 million  
2/17/2021Q4 2020($0.41)($0.46)($0.05)($0.46)$20.36 million$22.72 million  
11/9/2020Q3 2020($0.55)($0.38)+$0.17($0.38)$14.69 million$19.60 million  












Shockwave Medical Earnings - Frequently Asked Questions

When is Shockwave Medical's earnings date?

Shockwave Medical has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 6th, 2023 based off last year's report dates. Learn more on SWAV's earnings history.

Did Shockwave Medical beat their earnings estimates last quarter?

In the previous quarter, Shockwave Medical (NASDAQ:SWAV) missed the analysts' consensus estimate of $0.85 by $0.09 with a reported earnings per share (EPS) of $0.76. Learn more on analysts' earnings estimate vs. SWAV's actual earnings.

How can I listen to Shockwave Medical's earnings conference call?

The conference call for Shockwave Medical's latest earnings report can be listened to online. Listen to Conference Call

How can I read Shockwave Medical's conference call transcript?

The conference call transcript for Shockwave Medical's latest earnings report can be read online. Read Transcript

How much revenue does Shockwave Medical generate each year?

Shockwave Medical (NASDAQ:SWAV) has a recorded annual revenue of $489.73 million.

How much profit does Shockwave Medical generate each year?

Shockwave Medical (NASDAQ:SWAV) has a recorded net income of $216 million. SWAV has generated $6.42 earnings per share over the last four quarters.

What is Shockwave Medical's price-to-earnings ratio?

Shockwave Medical (NASDAQ:SWAV) has a trailing price-to-earnings ratio of 30.49 and a forward price-to-earnings ratio of 54.22. The price/earnings-to-growth ratio is 42.4.

What is Shockwave Medical's EPS forecast for next year?

Shockwave Medical's earnings are expected to grow from $3.61 per share to $4.36 per share in the next year, which is a 20.78% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:SWAV) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -